The post-genomic era has now arrived, and science and biology are on the threshold of a transition from understanding functions of single molecules and pathways in cells, tissues and whole organisms to understanding integrative systems. The endometrium is a dynamic tissue that responds to multiple stimuli, depending on physiological and environmental conditions, including steroid hormones, an implanting conceptus, withdrawal of steroid hormones, contraceptive steroids, selective steroid hormone receptor modulators, infection, transient cell populations, and metaplastic and neoplastic agents. High throughput technologies with regard to DNA, RNA and proteins are well positioned to enable a thorough understanding of the dynamic changes and integrative systems involved in endometrial maturation, desquamation, receptivity to implantation, infertility, pregnancy maintenance and failure, in¯ammation and infection, and malignant transformation. This monograph reviews some of the salient features of the new technologies and summarizes current information on endometrial biology derived from these approaches.
Introduction
The human genome project is nearly complete (Celera Genomics, 2001 ; Consortium of the IHGS, 2001 ) and currently, physical and genetic maps are being constructed with the goal of identifying genes associated with human diseases. Focus in science is shifting now to functional genomics, i.e. in the post-genomic era the functional analysis of genes and their products to elucidate their roles in cellular physiology/pathophysiology and tissue, organ, and whole organism organization and function. Rapidly emerging technologies that include high throughput expression analysis by microarrays (Schena et al., 1995; DeRisi et al., 1997) and proteomics (proteome = proteins encoded by the genome) (Wilkens et al., 1996) and accompanying strategies for data analysis (bioinformatics) now permit investigating expression levels of multiple genes and proteins simultaneously in cells, tissues, and whole organisms. In addition, comparisons of gene expression and protein expression are now possible between cells under various experimental conditions, between tissue samples under various physiological conditions, and between abnormal and normal tissues. These technologies may revolutionize biology and particularly medicine, since they afford the opportunity for gene discovery within cells, tissues, and organisms, to de®ne gene regulation, signalling pathways, and patterns of expressed genes that give insight into complex networksÐsome known, some previously unknown or not known to exist in particular systemsÐ that cross-communicate in cellular processes relevant to health and disease. In addition, they offer a powerful tool to de®ne normal tissue physiology, to de®ne disease classi®cations, and to elucidate pathogenesis of diseases (Golub et al., 1999) . Finally, these technologies offer the exciting promise of screening for genes and proteins for diagnostic purposes and for targeted drug discovery for new therapies. With regard to endometrium, it is now possible to pursue novel targets for fertility, contraception, breakthrough bleeding, infection, and neoplasia, affording the possibility of novel therapeutic approaches to these disorders. Application of gene-based technologies to human endometrium and its various functions and disorders are relatively recent and are reviewed herein. It is likely that more will emerge in the near future.
The tools of global gene pro®ling

Microarrays
Microarrays are mostly made by spotting DNA on solid supportsÐusually glass or nitrocellulose or nylon. Glass is preferable, since molecules can be arrayed in parallel, the procedure can be miniaturized, and¯uorescent dyes can be used for detection. Without diffusion into the glass, laser scanning microscopy can easily be performed. Two main procedures are used to produce DNA chips: photolithography and mechanical gridding. With photolithography (a process well-known in the microchip industry), a UV light passes through a mask that directs light in a stepwise manner where a photochemical reaction of oligonucleotide synthesis takes place on a siliconized glass surface. The masks can have openings that are as a few mm in diameter, permitting a density of several hundred thousand probes/cm 2 of glass. There is a length restriction to~25 nucleotides, and to overcome this, multiple probes per gene are used. The end result is a highdensity synthetic oligonucleotide array (Lipshutz et al., 1999) .
Mechanical gridding techniques use ink-jet or physical deposition of oligos or cDNA onto the support medium (Duggan et al., 1999) . Thus, arrayed probes can be oligomers (photolithograph and gridding) or cDNA (gridding). cDNA microarrays are also commonly synthesized as`designer' arrays, e.g. to screen for cytokine genes, transcription factors, oncogenes, cell cycle genes, etc. Many different support media are also available (Celis et al., 2000) . For endometrial cells and tissues, cDNA microarray and high-density oligonucleotide microarray studies have been performed and are summarized later in this review.
Data anaylsis
Data processing and analysis pose the greatest challenges to gene discovery, gene regulation, and characterization of gene function using these new technologies (Bassett et al., 1999; Brazma et al., 2000; King and Sinha, 2001; Celis et al., 2000) . A major underlying assumption is that changes in gene activity correspond to changes in corresponding gene and protein functions that have biological relevance. Bioinformatics is a relatively new ®eld comprising statistical and computational approaches to gathering, archiving, annotating, visualizing, analysing, and reporting genomic data (Kramer, 2003) . Generating lists of regulated genes or genes that differ between normal and abnormal tissue, for example, is an important ®rst step in data analysis. However, identifying genes whose expression patterns cluster with each other or with known genes, e.g. in a signalling pathway, can lead to identi®cation of new genes in tissues under various conditions. There are numerous ways to approach clustering large sets of data, and a common approach for microarray data uses Euclidean distance in n dimensional space, where n = the number of variables for each microarray element. The number of dimensions to be analysed derives from the number of treatment groups, the number of replicates, and changes in time, for example. Thus, the data are voluminous and`high dimensional' (n > 3) and require sophisticated computational and analytical approaches.
In data analysis, one is faced with the question of whether one should ®rst classify samples to be compared or examine the data and see where the`chips' fall. Unsupervised clustering analyses permit an unbiased discovery of expression periodicity (i.e. regularly recurring gene expression under certain conditions) and patterns of genes in tissues that do not require prior segregation into different groups (Eisen et al., 1998; Hastie et al., 2000) . Supervised clustering (e.g. GeneCluster program), however, can yield self-organizing maps (SOM) of related genes as an endpoint . SOM comprise a method of clustering complex data sets using selforganizing neural networks (Kohonen 1995) . In this approach, imposed structures of group boundaries are ®rst de®ned, which then allow speci®c hypothesis-testing with established methods. Voluminous amounts of data are generated, and of utmost importance is reliable identi®cation of true changes in gene expression. A recent report by Mariani et al. (2002) introduces an analysis of variable fold-change threshold, as apposed to the commonly chosen, ®xed fold-change threshold (e.g. 2-or 3-fold), to determine signi®cance for expression microarrays. In this approach, intensity-speci®c biases are eliminated, and a 5±10-fold reduction in the number of false positive changes is reported. A variety of statistical approaches to assess statistical signi®cance of a stated model or hypothesis can then be applied. A variety of programs can then be used to assess, for example, differential gene expression [e.g. principal component analyses (PCA: Joliffe et al., 1986) , statistical analysis of microarrays (`SAM': Tusher et al., 2001) ] and coordinated gene expression (Claverie, 1999) , and algorithms (e.g. K-means analysis) can be used to assess kinetic patterns of gene expression (Gordon, 1999) , to name a few. For an up-todate list of bioinformatics tools, the reader is referred to Draghici (2003) , although new algorithms and tools continue to be developed. Validation of gene expression and changes in expression are important and are individualized, in that most investigators validate only a few genes, since total validation of thousands (or tens of thousands) of genes is a gargantuan task for most laboratories. Minimizing false positives early in the data analysis and validation of gene expression, subsequently, are two important approaches to maximize data reliability and interpretation.
Lessons learned from gene pro®ling of human tissues
Two recent studies reported a compendium of gene expression in normal human tissues (Hsiao et al., 2001; Warrington et al., 2000) , and a number of interesting observations about gene expression in different tissues evolved from these. In the study by Hsiao et al. (2001) , 59 archived patient samples from 19 different tissues (not endometrium) were analysed by oligonucleotide microarrays. Of 7000 genes analysed, 451 are expressed in all tissue types and designated as housekeeping genes. However, the genes displayed signi®cant variation in expression levels among tissues and were suf®cient for discerning tissue-speci®c expression signatures. Similar results were reported by Warrington et al. (2000) . The authors suggest that the original de®nition of housekeeping genes by Watson et al. (1987) as genes that`are always expressed' be reevaluated as`maintenance genes', including b-actin and GAPDH. This is particularly relevant to endometrium, especially with regard to b-actin, which is regulated by estrogen (Cicatiello et al., 1992; Weisinger et al., 1999) , and therefore, the relevance of bactin as a housekeeping gene for normalization of expression of other genes in endometrium should be re-examined. The functional distribution of 451 maintenance genes present in all tissues examined is shown in Table I . In addition to the maintenance genes, there are subsets of tissue-selective genes that de®ne key biological processes that characterize each organ. While endometrium was not among the tissues investigated in these studies, other recent studies (see below) underscore unique endometrial gene products, especially of epithelial origin and of decidualized stromal cells. However, it is important to note that the vast majority of`tissue-selective' genes are rarely tissue-speci®c, since some degree of expression is found in most tissues, although the magnitude of expression is greatest in certain tissues (or cells or organs) under de®ned conditions (and thus are`tissue-selective'). Finally, within a given tissue, variant genes were identi®ed. These represented <2% of genes that are highly variable and several L.C.Giudice correspond to known disease phenotypes. In endometrium this is an unexplored topic and may reveal causes for endometrial abnormalities. The compendium of genes reported in these studies highlights similarities and differences among organs, systems and different individuals and provides a public resource (http://www/ hugeindex.org and http://phsiolgenomics.physiology.org/cgi/content/full/2/3/143) for future studies of gene expression, regulation, and pathophysiology (Hsiao et al., 2001) . Other public data repositories for gene expression pro®ling have been developed or are developing. For example, the National Center for Biotechnology Information (NCBI) has an online resource for retrieval of gene expression data, the`Gene Expression Omnibus', that can be accessed at http://www.ncbi.nlm.nih.gov/geo/. Also, the International Life Sciences Institute (ILSI) in collaboration with the European Bioinformatics Institute has developed a database and a standardized reporting format for microarray data that can be accessed at http://www.ILSI.org/. Some challenges of such databases include ensuring that submitted data meet minimal data quality standards and that suf®cient information (experimental, clinical) is included to allow interpretation of the data without overtaxing servers for data downloading.
Endometrial gene pro®ling
Recently, several studies have reported the results of endometrial gene discovery and gene expression, primarily in humans and mice. RNA has been derived primarily from isolated and cultured endometrial cells or endometrial tissue obtained by biopsy or from surgical specimens (in humans), and RNA isolated from whole uteri (in mice). Of critical importance in interpreting the data derived from endometrial cell cultures or endometrial biopsies and specimens obtained at surgery is acknowledging that cultured cells may have different responses in vitro compared with in vivo. These may be due to the processing of the cells, the culture medium used, concentrations of medium constituents, and loss of paracrine interactions with other cells in situ. Also, endometrial biopsies are a heterogeneous mixture of cell types, and data interpretation must be validated by classical methods for interpretation of particular cellular function(s). In addition, careful clinical characterization of the subjects donating the tissue, their hormonal state, age, history of infertility, endometriosis, pregnancy history, obesity, diabetes, and other medical conditions, is essential to minimize inter-subject variability and to maximize data reliability. This is most challenging with human subjects, whereas animal models provide more uniformity experimentally, and in this regard offer further value for validating ®ndings with human tissues and cells. However, with mouse studies the use of whole uterus to investigate endometrial gene expression requires classical validation in the tissue of interest.
Studies with human endometrial cells include using cDNA and oligonucleotide analyses of endometrial stromal cell differentiation stimulated by cAMP T progesterone (Popovici et al., 2000; Brar et al., 2001; Tierney et al., 2002) , compared with nondecidualized endometrial stromal cells. Some of these were timecourses and have resulted in important insights into biochemical pathways participating in the process of endometrial stromal decidualization with new players being involved. Endometrial biopsies have also been analysed by oligonucleotide microarray analyses, with comparisons being made between the window of implantation and late proliferative phase endometrium Borthwick et al., 2003) and pre-receptive versus receptive endometrium (Carson et al., 2002; Riesewijk et al., 2003) . Subtractive cDNA hybridization and differential display PCR have been useful in comparing gene expression in endometrium or endometrial cells under different conditions and are described in this context below. In addition, exciting information on implantation site and interimplantation site gene expression in the mouse model has been reported (Reese et al., 2001 ; studies by Salamonsen et al., 2002) and may give insight into human implantation. Studies on mouse endometrium from a global gene expression perspective after administration of a progesterone receptor (PR) antagonist to pregnant mice provide additional insights into steroid-hormone regulated genes in this tissue (Cheon et al., 2002) . Furthermore, the genetic programme of human trophoblast differentiation (from cytotrophoblast to syncytiotrophoblast) has been reported and provides insight into trophoblast candidate genes that may participate in cross-talk with the maternal endometrium. Finally, disorders of the endometrium have been investigated, including differences in gene pro®ling in eutopic endometrium of women with endometriosis versus ovarian endometriomas (Eyster et al., 2002) and eutopic endometrium of women with versus without endometriosis (Kao et al., 2003) , as well as constitutive and hormonally regulated genes during endometrial neoplastic transformation (Mutter et al., 2001; Risinger et al., 2003) . These are reviewed herein.
Endometrial stromal cell differentiation
During implantation in humans, placental trophoblasts invade into the maternal endometrial stromal cell compartment. Decidualization of stromal cells is necessary for successful implantation and represents differentiation of the stromal cells to a distinct morphological appearance accompanied by a unique biosynthetic and secretory phenotype (Noyes et al., 1975; Ferenczy and Bergeron, 1991; Irwin and Giudice, 1999) . It is initiated independently of conception during the late secretory phase of normal ovulatory cycles. Current evidence supports roles for progesterone as well as cAMP in the process of endometrial stromal differentiation, and decidualization in vitro can be effected with progesterone, after estradiol (E 2 ) priming, and also by cAMP and other ligands that activate the protein kinase A-dependent pathway (Zhu et al., 1992 proteins and factors are up-regulated or induced and some factors are down-regulated during the process of decidualization. The up-regulated factors are believed to participate in paracrine signalling to other cell types in the endometrium during normal cycles and in early pregnancy. In addition, a unique extracellular matrix (ECM) is the net result of endometrial stromal decidualization, one that is rich in laminin, heparan proteoglycans, and type IV collagen (Ferenczy and Giudice, 1994, review) . In the absence of implantation and upon steroid hormone withdrawal, the stromal compartment contributes to activation of matrix-degrading enzymes to effect tissue desquamation and endometrial bleeding as the menses (Irwin and Giudice, 1999 ). The precise molecular mechanisms underlying the process of decidualization have not been completely understood, and a comprehensive analysis of signalling molecules and uniquely expressed factors is wellsuited to global gene pro®ling of human endometrial stromal cells in response to a variety of agents that are known to promote decidualization.
In the study by Popovici et al., 2000) , human endometrial stromal cells were decidualized with progesterone after E 2 priming or with cAMP. Achieving a secretory phenotype [measured by insulin-like growth factor binding protein (IGFBP)-1 secretion into the conditioned medium (CM)] in response to progesterone after E 2 priming often takes >1 week, and the response to cAMP in achieving the same phenotype (approximately equivalent levels of IGFBP-1 in the CM) takes~1±2 days. Thus, in the study by Popovici et al., endometrial stromal cell gene expression was investigated after 10 days of E 2 + progesterone treatment and after 48 h of 1 mmol/l 8-BrcAMP treatment, compared with no treatment (nondecidualized controls). Using a cDNA microarray for 588 annotated genes, this study revealed regulation of many known endometrial stromal cell genes, as well as numerous genes not previously appreciated to be expressed in endometrium. Up-regulation of speci®c cytokines, growth factors, nuclear transcription factors, members of the cyclin family, and mediators of the cAMP signal transduction pathway were found. In addition, up-regulation of the insulin receptor, some neurotransmitter receptors, neuromodulators, the FSH receptor, inhibin/activin b A subunit, inhibin a, some members of the angiotensin/renin family, and the tumour necrosis factor (TNF)-related apoptosisinducing ligand (TRAIL) were observed. The study by Popovici et al. was the ®rst to use microarray technology to assess differentiation of human endometrial stromal cells in vitro, and in so doing con®rmed many of the`players' in the decidualization process. Reassuringly, many of these known genes have also been implicated in decidualization of the endometrial stromal cells in vivo (Giudice, 2002; review) . However, a major contribution of this study was its discovery component, i.e. new members of the transforming growth factor (TGF)-b family up-regulated during decidualization, the expression of neuromodulators and neurotransmitter receptors, many immune componentsÐ many of which had not previously been recognized in this differentiation process. Delineating the functions of these newly found players in the decidualization process is of utmost importance in understanding the function of this unique cell type in human endometrium and is a challenge for the future.
The process of decidualization of the stromal cells was subsequently investigated on a more global scale by two groups, each investigating the temporal expression and regulation of nearly 7000 genes. Brar et al. (2001) , using the Incyte human GEM-V microarray investigated gene expression of human term decidual ®broblasts in response to E 2 + progesterone + 8Br-cAMP at 0, 2, 4, 6, 9, 12 and 15 days. Of 6918 genes analysed, 121 were induced >2-fold, 110 were downregulated, and 50 demonstrated biphasic behaviour. Dynamically regulated genes clustered into nine patterns of gene expression as a function of time. The genes were classi®ed biologically into ®ve categories: cell and tissue function, cell and tissue structure, regulation of gene expression, expressed sequence tags (EST, short stretches of nucleotide sequences), and unknown function. During the process of decidual ®broblast decidualization, the authors found marked changes in proteins involved in extracellular organization, cytoskeletal organization, and cell adhesion, transcription factors, members of the IGF family, early induction of genes involved in mitogen-activated protein kinase signalling, as well as others (Table II) . These ®ndings have provided insight into multiple processes occurring during decidualization. Many genes were reprogrammed (i.e. changed expression) within speci®c functional groups and gene families with simultaneous induction and down-regulation of sets of genes with related functions, suggesting that reprogramming of gene expression within functional categories represents a fundamental aspect of cellular differentiation in general, and for the decidualizing pregnancy ®broblasts, in particular. In another study, Tierney et al. (2002) , using Affymetrix high density oligonucleotide arrays, investigated genes expressed by human endometrial stromal cells decidualized in vitro in response to 8Br-cAMP at 0, 2, 4, 6, 12, 24 and 48 h. They also found reprogramming of genes and gene families during the decidualization process, consistent with development of the secretory phenotype. That many up-and down-regulated genes were commonly found in both studies attests to the reliability of the data for these genes and gene families participating in the process of decidualization. Validation of gene expression in exvivo tissue specimens is essential for further data interpretation. Furthermore, both studies demonstrated reprogramming of genes during the temporal sequence of stromal decidualization, underscoring multiple processes occurring during differentiation of the stromal cell to the decidual phenotype and providing insight into stromal functions in cycling endometrium and decidua.
In addition to these studies, animal studies in which homologous recombination and gene knockouts have resulted in defective decidualization are extraordinarily important, as they provide`proof of principle' of a particular agent being L.C.Giudice important in the decidualization process (Lim et al., 2002; review) . Included in the latter are homeobox genes Hox A-10, Hox A-11, interleukin (IL)-11 and leukaemia inhibitory factor. It should be noted, however, that decidualization in mice occurs in the presence of an embryo or can be induced mechanically, and players promoting decidualization in humans may differ. However, increasing evidence suggests that some of the components found in mouse implantation may also play a role in decidualization in human endometrium.
Whole tissue
Two sets of experiments with well-de®ned times in the menstrual cycle, using human endometrium have been performed by four groups. These are shown schematically in Figure 1 . Two groups compared genes expressed in the window of implantation versus late proliferative endometrium, and two groups compared genes expressed in receptive endometrium (in the window of implantation) versus pre-receptive endometrium (early secretory phase). These are described below.
Window of implantation versus proliferative phase endometrium
In the study by Kao et al. (2002) , global gene pro®ling of 12 686 genes was investigated in endometrial biopsies timed to the LH surge (LH+8±10 (window of implantation, peak A dominant feature of decidual ®broblast differentiation program is the loss of mRNA for numerous integrin, keratin, and collagen mRNA simultaneous with the induction of matrix metalloproteinases-2 and -11 and cathepsin K. In addition, there is induction of decorin, ®bromodulin, and epidermal growth factor (EGF)/®bulin-like extracellular proteinase. This suggests that major extracellular remodelling accompanies decidualization. Repressed genes are shown in bold text. (Adapted from Aronow et al., 2001 ; with permission.) Figure 1 . Schematic of experimental designs comparing genes expressed at various times in the menstrual cycle in human endometrium (see text). WOI = window of implantation circulating progesterone + E 2 ) compared with late proliferative phase (peak E 2 ) in normally cycling subjects who did not have endometriosis. Individual samples were processed and mean levels of 156 genes were up-regulated and 345 genes downregulated b2-fold in the window of implantation versus the late proliferative phase. Up-regulated genes included: apolipoproteins, phospholipase A2, mammaglobin, osteopontin, glycodelin, N-acetyl-6-sulphotransferase (important for glycoprotein synthesis), members of the TGFb-signalling pathway, the IGF system, a variety of immune modulators, antibacterial modulators, metallothioneines and other genes involved in detoxi®cation and heavy metal availability, members of the Wnt signalling pathway (e.g. Dikkopf-1, a Wnt inhibitor), water and ion transporters, transcription factors, apoptosis family members, and others. N-Acetyl 6-sulphotransferase is of particular interest since this enzyme synthesizes in the endometrium the ligand of L-selectin, shown recently to be expressed by the trophectoderm and to be important in human embryo attachment to the luminal epithelium (Genbacev et al., 2003) . Down-regulated genes included intestinal trefoil factor, tenascin C, matrilysin (matrix metalloproteinase-7), frizzled related protein (FRP-HE, a Wnt inhibitor), and others. Validation of multiple up-and down-regulated genes was conducted and con®rmed differential expression.
In the study by Borthwick et al. (2003) , genes and EST were investigated in pooled endometrial biopsy samples timed to the LH surge versus late proliferative phase, using Affymetrix microarrays. Note that this set of experiments is identical to that of Kao et al., except that the samples were pooled before hybridization to microarrays, whereas in the study by Kao et al., processed RNA from individual endometrial biopsies were hybridized to microarrays prior to data analysis. Many of the genes found by Boorthost et al. agreed with the ®ndings of Kao et al. The former group also investigated the dataset for absolute expression and found >200 genes commonly and abundantly expressed by proliferative and secretory endometrium and included: ribosomal RNA, genes for structural proteins, and others (Borthwick et al., 2003) . In addition, they reported the relative abundance of speci®cally regulated genes, as well as fold-change in the implantation window versus late proliferative phase. By querying databases, progesterone and estrogen response elements (PRE and ERE) were identi®ed in the promoters of many genes regulated (up or down) in this study. Of note is the presence of candidate ERE in intestinal trefoil factor, up-regulated in the proliferative phase in both the study by Kao et al. (2002) and Borthwick et al. (2003) , and candidate PRE in monoamine oxidase, up-regulated in the secretory phase in both studies. Mining databases affords an important tool for investigating candidate response elements and provides guidance toward searching for, for exampe, steroid hormone-regulated genes in endometrium and other tissues.
We have recently analysed the data from Kao et al. (2002) and Borthwick et al. (2003) for EST that had >3-fold change (L.Giudice, A.Germeyer, S.Tulac and C.Dosiou, unpublished data). EST are short stretches of nucleotide sequences (200±500 bp) from randomly selected clones in a cDNA library. Thousands of EST have been generated, and the NCBI maintains a single public directory, dbEST, with information on nucleic acid sequences with notations of source material, method of data generation, and authors and citations. Table III shows selected EST in the window of implantation for which there is a known corresponding gene or with which there is signi®cant homology, as well as GenBank accession number, and comments on function. Of note are some EST corresponding to genes that were identi®ed in the original analyses, e.g. up-regulation of phospholipase A2 (prostaglandin synthesis), metallothioneines 1H and 1F (detoxi®cation, zinc storage), beta defensin (antibacterial), and LRP (important in Wnt action). This is to be expected, since EST on the oligonucleotide chips derive from a variety of sources and would be anticipated to have some overlap with oligonucleotides derived from sequences of speci®c genes. Of particular interest, however, are genes not previously identi®ed in the analyses, including up-regulation of aquaporin 3 (involved in water transport), apolipoprotein C-I (involved in lipid transport), retinoic acid receptor responder protein 1, and down-regulation of aryl-hydrocarbon receptor nuclear translocator, PECAM-1, and the CCR1 chemokine (C-C motif) receptor 1 [important in signalling for RANTES and monocyte chemotactic protein 1 (MCP-1)]. Also, down-regulation of FBXL7 F-box protein (leucine-rich repeat protein), important in ubiquitination, was found in both studies. The physiological signi®cance of this particular ®nding in endometrium during the implantation window is uncertain currently, although ubiquitination is known to be important in protein turnover.
Receptive versus pre-receptive endometrium Carson et al. (2002) investigated changes in endometrial gene expression during the early luteal (pre-receptive) compared with mid-luteal (receptive) transition, using Affymetrix microarrays. They found 323 genes that were up-regulated and 370 genes that were down-regulated >2-fold during the transition. Many regulated genes were common to those reported by Kao et al. (2002) , including, but not limited to, claudin-4 [also known as the Clostridia Perfringens enterotoxin (CPE) receptor], osteopontin, glycodelin, matrilysin, and FRP-HE. Twenty per cent of the genes changing during the transition encode cell surface receptors, adhesion and ECM proteins, and growth factors, and down-regulation of matrilysin, Indian hedgehog receptor, FRP-HE, recombination activating gene (RAG2), and others. Select genes were validated by Northern analysis and immunohistochemistry. The latter demonstrated that the E type prostaglandin (EP1) receptor is expressed abundantly in the cell periphery of glandular epithelium and is absent from stroma, and the leukotriene B4 receptor is expressed intracellularly in both glands and stroma. Also, the CPE receptor/claudin is expressed primarily in glandular epithelium and somewhat in stroma. (Carson et al., 2002) . Riesewijk et al. (2003) also conducted a study on gene expression pro®ling of mid-versus early secretory endometrium, in an experimental design very similar to that of Carson L.C. Giudice et al. (2002) . Two main exceptions were that in the study by Riesewijk et al., the same subject underwent endometrial biopsy at LH+2 and LH+7, whereas in the study of Carson et al., different subjects' samples were used. Also, more precise parameter setting at LH+2 and LH+7 was used in this study. In this report, 153 genes were up-regulated >3-fold, and 58 were down-regulated. Interestingly, about 1/3 of the up-regulated genes agreed with data from Kao et al. (2002) and only 10% with data from Carson et al. (2002) . Even less agreement was found in the down-regulated genes. The differences may re¯ect subtle hybridization conditions and details of the experimental aproaches (see above).
Other techniques have been used to investigate differences in gene expression between secretory and proliferative phase endometrium. These include subtractive cDNA hybridization, an early, large scale pro®ling method in which cDNA libraries derived from two tissues or cell cultures are compared, using an excess of one library. Following denaturation and hybridization, cDNA common to both tissues anneal, and the unique cDNA remain single-stranded. This approach revealed glycodelin to be a speci®c product of secretory phase endometrium (Vaisse et al., 1990) , and this protein is now widely believed to participate in endometrial receptivity (Seppala et al., 2002) . Also using this technique, Higushi et al. (1995) found marked up-regulation of tissue inhibitor of metalloproteinase-3 (TIMP-3) in secretory, compared with proliferative, phase endometrium. As invading trophoblasts secrete matrix metalloproteinases (e.g. MMP-9) (Librach et al., 1996) , having TIMP-3, a speci®c inhibitor of MMP, expressed in endometrium during trophoblast invasion is compatible with control of invasion of the placenta into the maternal decidual compartment. Indeed, in in-vitro studies invasion of human trophoblasts into Matrigel is inhibited by TIMP-3 (Librach et al., 1996) .
Endometrial-trophoblast interactions/implantation
Trophoblast/endometrial in-vitro and in-vivo models Using human endometrial stromal cells co-cultured with BeWo cells, a choriocarcinoma cell line, as a model of stromal±-trophoblast interactions, Cowan et al. (1999) investigated changes in gene expression using differential display PCR. The approach of differential display is similar to subtraction hybridization and uses random oligonucleotide primer sets and PCR to amplify fragments of differentially expressed cDNA from different tissues or cells. Several genes were identi®ed to be up-and down-regulated and the complement of genes differentially regulated was a function of the degree of endometrial stromal decidualization before being challenged by the trophoblast cell line and was a function of the duration of exposure. One clone identi®ed as Soares pregnant uterus gene was up-regulated in decidualized stromal cells exposed in vitro Kao et al. (2002) and Borthwick et al. (2003) . VLDL = very low density lipoprotein; HDL = high density lipoprotein.
to BeWo for 4 h. This same gene has been identi®ed during stromal decidualization (Tierney et al., 2002) , and although far from being validated, the data suggest that perhaps the trophoblast accelerates decidualization of stromal cells. This may be particularly important in the trophoblast affecting the receptivity of the endometrium, although considerable experimental evidence is required before the molecular de®nition of these interactions is well understood. In a recent study by Chen et al. (2002) differentially expressed genes in early human gestational decidua and chorionic villi were analysed, on a global scale, using a 9600 cDNA microarray. In all, 641 genes were highly expressed in both decidua and villi, underscoring potential redundancy of particular factors and processes at the placental±decidual interface. In addition, 49 genes were more highly expressed in decidua, including connective tissue growth factor, IGFBP-1, IGFBP-4, cathespin L, IL-1 type I receptor, the insulin receptor, and S-100 calcium-binding protein, in agreement with studies of human endometrial biopsies in the implantation window (Carson et al., 2002; Kao et al., 2002) and also decidualizing human endometrial stromal cells (Popovici et al., 2000; Brar et al., 2001; Tierney et al., 2002) . In addition, 75 genes displayed higher expression in chorionic villi, compared with decidua, including inhibin b A subunit, stromelysin-3, glycoprotein hormones a chain precursor, human growth hormone variant, leukaemia inhibitory factor receptor, and other cell growth and cycle regulators, apoptosis-related factors, hormones, cytokines, stress-response factors, signal transducers, and others. This study contributes to the understanding of genes expressed in decidua and in chorionic villi in early gestation, and more information on the dynamics of changes in gene expression as a function of time in these compartments at the placental±decidual interface as gestation progresses will likely give insight into the multiple processes occurring throughout early implantation and placentation.
Gene regulation in the implantation and interimplantation sites in the mouse
In the mouse model, implantation occurs on day 4 (where day 0 = day of the vaginal plug). Yoshioka et al. (2000) , using oligonucleotide microarrays, identi®ed genes differentially expressed just before implantation (day 3.5) and post-implantation (day 5.0). The authors found that 192 genes were upregulated and 207 were down-regulated during the transition between pre-and post-implantation. Since decidualization is markedly enhanced on day 5, most of these genes likely represented decidual, rather than implantation-speci®c, genes. Several genes were found to agree with ®ndings of a recent, subsequent study (Cheon et al., 2002) on PR-regulated genes (see below).
Also, using the mouse model, Reese et al. (2001) investigated global gene pro®ling with oligonucleotide microarray technology of implantation sites and interimplantation sites, as well as uterine gene expression pro®les of progesteronetreated, delayed implanting mice compared with those in which delayed implantation was terminated by the administration of estrogen. They found 36 up-and 27 down-regulated genes at the implantation sites, compared with the interimplantation sites. In delayed implantation, 128 genes were up-regulated, and 101 were down-regulated. A combined analysis revealed speci®c up-regulation of 27 genes both at the implantation site and during uterine activation, representing a broad diversity of molecular functions. However, the majority of genes that were decreased in the combined analysis were related to the immune response of the host, underscoring the importance of these genes in regulating the uterine environment for an implanting blastocyst.
Using RNA differential display PCR, Salamonsen et al. (2002) also investigated genes differentially expressed in implantation versus interimplantation sites. They found differential regulation of splicing factor SC35, calbindin-D9k, and monoclonal non-speci®c suppressor factor (MNSF)-b. SC35 mRNA participates in removal of introns from pre-mRNA and was up-regulated in implantation versus interimplantation sites. In contrast, calbindin-D9k, a regulator of calcium and expressed in the epithelium, was up-regulated by progesterone and was signi®cantly lower in implantation sites on days 4.5±5.5 of pregnancy. MNSF-b, a cytokine involved in regulation of the immune system, showed lower expression in implantation sites, consistent with the data of Reese et al. (2001) .
Oligonucleotide microarrays were used recently to identify genes regulated by progesterone acting through the PR, by administering a PR antagonist, RU486, to mice on day 3 of pregnancy and collecting uteri on day 4 (and subsequentlȳ ushing out the embryos) (Cheon et al., 2002) . Using a 2-fold change threshold, 78 genes were down-regulated in the RU486 treated mice, compared with vehicle controls, and 70 genes were up-regulated. Validation by immunohistochemistry revealed that subsets of progesterone-regulated genes identi®ed by the microarray analysis demonstrated distinct cell typespeci®c expression patterns, and that the spatio-temporal expression of these genes mimicked the expression of PR in the uterus during pregnancy, supporting their regulation by progesterone. Interestingly, several of the down-regulated genes correspond to those observed by Yoshioka et al. (2000) , and include amphiregulin, ®sp 12 (a member of the connective tissue growth factors), epidermal-12/15-lipoxygenase, cathespin D, pyruvate carboxylase, follistatin, Rho B, and laminin-2-a2 chain. Some of these are of interest because of their roles, e.g. in metabolism [e.g. lipoxygenases and other metabolic enzymes likely to be important in the known increase in oxygen and glucose consumption in uterine tissues that occurs on day 4 (Serani and Heald, 1971) ] and in suppressing FSH during pregnancy (follistatin). Several genes were also in agreement with the study by Reese et al. (2001) in which the embryos were in the implantation sites during the analysis, and a different experimental paradigm was used. The study by Cheon et al. (2002) is also noteworthy for the upregulated genes in response to RU486. By administering RU486, an anti-estrogen ICI 182780, or a combination of both inhibitors, and subsequent Northern analysis of select genes L.C.Giudice shown to be up-regulated by RU486 in the microarray analysis, the authors found that ICI 182870 sharply inhibited RU486 upregulation. The data highly support the interpretation that hormone-occupied PR represses estrogen and estrogen-receptor-regulated expression of these genes in the normal pregnant uterus, and with the binding of RU486 to the PR, this repression is released, thereby permitting ER induction of gene expression (Cheon et al., 2002) .
Commonality of several genes and gene families being upand down-regulated in early implantation (compared with preimplantation or at interimplantation sites) and P-regulated genes underscores the validity of the microarray approach by different investigators using tissues with multiple cell types. In addition, the data provide important leads to mechanisms involved in the implantation process. Interestingly, several genes are common with those reported in receptive human endometrium (Borthwick et al., 2003; Carson et al., 2002; Kao et al., 2002; Riesewijk et al., 2003) , underscoring conservation of mechanisms across species, and with differences underscoring the uniqueness of the implantation process across species.
Gene regulation during trophoblast differentiation
An elegant set of experiments conducted by Aronow et al. (2001) has demonstrated global gene changes accompanying human trophoblast differentiation in vitro from cytotrophoblast to syncytiotrophoblast. Using high-density oligonucleotide microarray analysis of human term trophoblasts cultured in vitro for up to 6 days and K-means kinetic algorithmic analysis, they found multiple genes and gene families reprogrammed during the differentiation process. The differentiation programme is shown schematically in Figure 2 . Some of the early expressed genes may be important as the cytotrophoblast invades into the maternal endometrium. The syncytiotrophoblast phenotype likely re¯ects the transport functions of this cell type during gestation. While in-vitro differentiation may not completely re¯ect changes occurring in vivo, the gene families expressed in this differentiation process are consistent with known changes observed in vivo during trophoblast invasion into the decidua and also the transport functions of the syncytiotrophoblast during pregnancy, Putting it all together: a model of endometrial receptivity during embryonic implantation Putting all the data together, the following model (Figure 3) is proposed for events in the endometrium as it prepares for and participates in embryonic implantation. As an embryo attaches to the endometrial epithelium, tethering and rolling on the endometrial surface, and ®nally bridging to cell surface carbohydrates and proteins, mechanisms must be in place in the maternal endometrium for synthesis of molecules participating in these events. Once attachment occurs, a set of mechanisms is likely to be put into motion for endometrial±-stromal interactions, intrusion of the trophoblast into the stromal compartment, and guidance of the trophoblast to the maternal spiral arteries, while maintaining integrity of the ECM and anticoagulation. It is envisioned that embryo±-endometrial interactions involve ion transport and signalling through paracrine mechanisms via growth factors and cytokine families, as well as adaptation of guidance mechanisms similar to those used in angiogenesis and, perhaps, neuronal migration to target the trophoblast through the stroma to reach the maternal vasculature. The immune system must facilitate tolerance of the implanting allograph, and other protective mechanisms (e.g. anti-bacterial, detoxi®cation) are probably important to maximize viability of the implanting conceptus. Also, tissue integrity is important, as are changes in ECM composition, to assure an anchor for the conceptus and in signalling to trophoblast and endometrial cells. It is likely that many of these events occur simultaneously, some occur in microenvironments uniquely, and others occur in strict temporal, as well as spatial, fashion. While this model is rudimentary, it provides a framework for the role of the genes identi®ed in the above studies in these processes. It is important to note that despite the anticipated interactions between the endometrium and the conceptus, based on gene expression in the endometrium during the implantation window described herein, the microarray approach in human biopsy specimens provides a static snapshot of gene expression in the endometrium in the absence of an embryo and does not reveal the dynamic dialogue that occurs minute-to-minute during embryonic implantation between the endometrium and the embryo. Nonetheless, it provides insight into the molecular pathways, molecular signals, and physiological processing that await an embryo should nidation occur. Studies with trophoblast/endometrial cell culture models and other in-vitro models of implantation, as well as animal studies on homologous recombination and transgenic models, will give additional insight into these participants and their functional roles in endometrial physiology and pathophysiology.
Endometrial disorders
Endometriosis
Endometriosis is clinically associated with pelvic pain and infertility, with implantation failure suggested as an underlying cause for the observed infertility . Eutopic endometrium of women with endometriosis provides a unique experimental paradigm for investigation into molecular mechanisms of its reproductive phenotype and an opportunity to identify markers for the disease. Using high-density oligonucleotide microarray technology, Kao et al. (2003) investigated differentially regulated genes in endometrium from women with, versus without, endometriosis. Of the 12 686 genes analysed, 91 genes were signi®cantly >2-fold increased in their expression, and 115 genes were signi®cantly >2-fold decreased. Unsupervised clustering demonstrated down-regulation of several known cell adhesion molecules, endometrial epithelial secreted proteins, and proteins not previously known to be involved in the pathogenesis of endometriosis, as well as up-regulated genes. Selected dysregulated genes were validated, and of note is the marked down-regulation of N-acetylglucosamine-6-O-sulphotransferase (important in L-selectin ligand biosynthesis), glycodelin, IL-15, and Dickkopf-1, and up-regulation of Semaphorin E. Based on the ®ndings in this study [and others, Giudice et al., 2002; (review) ], dysfunctions in embryonic attachment, survival, and signalling are mechanisms postulated to be operational in eutopic endometrium of women with endometriosis that contribute to the infertility often associated with this disorder.
A recent study investigated differences in gene expression in ovarian endometriomas versus eutopic endometrium (Eyster et al., 2002) . Eyster et al. investigated 4133 genes using a cDNA microarray and found that eight genes were upregulated in ovarian endometriomas compared with eutopic endometrium. These included b-actin, a2-actin, vimentin, 40S ribosomal protein S23, Ig-l light chain, Ig germline H chain G-E-A region g-2 constant region gene, MHC class IC, and complement component 1 S subcomponent. The authors suggest that the structural proteins are important to anchor lipid droplets, important for steroid hormone biosynthesis by the endometriotic tissue. Up-regulation of select immune genes supports immune dysfunction contributing to the pathogenesis of endometriosis, although precise mechanisms still remain to be de®ned.
Using differential display PCR, Lundeen et al. (2000) compared genes expressed in endometriotic implants and eutopic endometrium from women with and without endometriosis, during the mid-proliferative phase of the cycle. They found up-regulation in ectopic and eutopic endometrium of women with endometriosis compared with normal eutopic endometrium, expression of a zinc-®nger transcription factor coded by the early growth response (EGR)-1 gene. EGR-1 is regulated by E 2 , IL-1b, IL-6 and TNF-a and may enhance angiogenesis via regulation of vascular endothelial growth factor and its receptors. Many of the upstream regulators of EGR-1 are associated with endometriosis, and this gene may play a central role in the pathogenesis of this disorder .
Recently, using a cDNA microarray approach, Taylor and colleagues demonstrated altered expression of a cell cycle suppressor gene, Tob-1, in endometriotic stromal cells (Lebovic et al., 2002) . Treatment with IL-1b of stromal cells isolated from endometriotic lesions and eutopic endometrium had differential responsiveness in these two cell types, with IL1b down-regulating Tob-1 in endometriotic stromal cells, and having minimal effect on normal stromal cells. Together, these results suggest that IL-1b promotes growth of endometriotic lesions through inhibition of Tob-1 and imply an association of IL-1b with an alteration of cell-cycle gene expression in cells derived from endometriotic implants (Lebovic et al., 2002) . et al. (2001) , using oligonucleotide microarrays, investigated genes that distinguish neoplastic transformation versus normal human endometrium. Analysis of gene expression in ten malignant endometria, compared with normal endometria, revealed diminished expression levels in the cancers. Fifty genes provided discrimination between normal and malignant groups and were primarily decreased in expression in the malignant endometrium. One hundred genes that were hormonally regulated in normal tissues were expressed in a disordered and heterogeneous fashion in cancers, with tumours resembling proliferative, more than secretory, endometrium in gene expression pro®les. Thus neoplastic transformation is accompanied by predominant loss of many genes constitutively expressed in normal endometrium and absence of expression pro®le that characterizes the anti-tumorigenic progestin response. In a recent study, Risinger et al. (2003) investigated gene expression pro®les among different histological types of endometrial cancer: Type I, associated with unopposed estrogen exposure; and Type II, which are often poorly differentiated. Using cDNA microarrays, the authors identi®ed 75 genes that were differentially expressed. Real-time PCR of six genes [AGR2, trefoil factor 3 (TFF3), DUISP6, IGF-2, FOLR1 (a forkhead protein), and ubiquitin thiolesterase (UCHL1)] validated the microarray ®ndings. In addition, class prediction models reproducibly de®ned 30 out of 32 cancers as either Type I or II. The authors speculate that a vaccine targeted for FOLR has been developed for ovarian carcinoma and potentially could be used adjunctively in treatment of speci®c endometrial cancers that overexpress this gene. These data underscore the potential utility of microarray analysis of tumour specimens for predicting clinical outcome and for novel targets for cancer therapeutics.
Neoplastic transformation
Mutter
Conclusions
New advances in technology and bioinformatics are enabling elucidation of signatures characteristic of endometrial statesÐ both normal and abnormal, as well as in response to steroid hormones, infection, and other stimuli. With the sequencing of the human genome, ESTs can now be identi®ed, and mining this resource will add further to our understanding of endometrial function under a variety of conditions. ESTs and mining public databases for steroid hormone response elements are just two approaches that will enhance understanding of endometrial function and dysfunction. Of course, validation using proteomic approaches will contribute to the validity of select gene functions in endometrial proliferation, secretory transformation of the epithelium, decidualization of the stroma, implantation, tissue desquamation in the absence of implantation, and changes in the endometrium due to in¯ammation or infection. Recently, the National Institutes of Health announced an endometrial database, derived primarily from data in the studies reviewed herein, that can be accessed at: http://slab.bcf.bcm.tmc.edu/endometrium/baylor.jsp. The use of this database, as well as of tissue microarrays, in which serial sections of multiple tissues are used for immunohistochemistry or in-situ hybridization (Kononen et al., 1998; Camp et al., 2000) , will surely expedite the validation process, on a global scale. Sections of tissue microarrays permit parallel in-situ detection of DNA, RNA and protein targets in each specimen on the array, and serial sections allow high-throughput analysis of hundreds of molecular markers in the same set of specimens. We are on the threshold of a revolution in medicineÐ in discovery, in diagnostics, and in therapeutics, with the ultimate goal of improving health and minimizing disease. Genomics is just the beginning ¼
